Merck reported a whopping $1.6 billion loss for the fourth quarter, mostly because of massive accounting charges related to its $4.85 billion Vioxx settlement. During the same period last year, Merck posted a $473.9 million profit. Meanwhile, some Florida patients left out of the Vioxx deal now want in. Report [1] | Report [2]
Links:
[1] http://www.nasdaq.com/aspxcontent/NewsStory.aspx?cpath=20080130\ACQDJON200801301006DOWJONESDJONLINE000563.htm&selected=9999&selecteddisplaysymbol=9999&StoryTargetFrame=_top&mkt=WORLD&chk=unchecked&lang=&link=&headlinereturnpage=http://www.international.na
[2] http://ap.google.com/article/ALeqM5iu40jZLNwRzuYnnj_DctLVaJEnYwD8UFRREO0